Anti-Mouse MHC Class II (I-A) [Clone Y-3P] – Purified in vivo GOLD™ Functional Grade
Anti-Mouse MHC Class II (I-A) [Clone Y-3P] – Purified in vivo GOLD™ Functional Grade
Product No.: H470
Clone Y-3P Target MHC class II (I-A) Formats AvailableView All Product Type Hybridoma Monoclonal Antibody Isotype Mouse IgG2a k Applications B , FC |
Antibody DetailsProduct DetailsReactive Species Mouse Host Species Mouse Recommended Dilution Buffer Immunogen BALB/c x C57BL/6 F1 mouse spleen cells Product Concentration ≥ 5.0 mg/ml Endotoxin Level < 1.0 EU/mg as determined by the LAL method Purity ≥95% monomer by analytical SEC ⋅ >95% by SDS Page Formulation This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration. State of Matter Liquid Product Preparation Functional grade preclinical antibodies are manufactured in an animal free facility using only in vitro protein free cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. Storage and Handling Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at ≤ -70°C. Avoid Repeated Freeze Thaw Cycles. Regulatory Status Research Use Only Country of Origin USA Shipping 2 – 8° C Wet Ice Additional Applications Reported In Literature ? B, FC Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionDescriptionSpecificity Y-3P activity is directed against mouse MHC class II (I-A) glycoprotein antigens,
including the haplotypes I-Ab, I-Af, I-Ap, I-Aq, I-Ar, I-As, I-Au, I-Av, and weakly I-Ak. Y-3P
also reacts with the equivalent complexes in rats. Background H-2, the murine major histocompatibility complex (MHC), is composed of a diverse group of
antigens divided into class I and II proteins that function in immune response1. Class II
molecules, also known as Ia antigens, regulate recognition of foreign antigens on the surfaces of
antigen presenting cells and play a major role in the mixed lymphocyte response2. Mice have
two class II isotypes, I-A and I-E, each of which is a glycoprotein composed of an ⍺ and β
subunit. The N-terminal α1 and β1 domains of the MHC class II isotype form the antigen-
binding groove, which binds 13-25 aa peptides derived from exogenous antigens3. On APCs, MHC class II molecules play a critical role in the adaptive immune response by presenting phagocytosed antigens to helper CD4 T cells. The T cell receptor (TCR)/CD3 complex of CD4 T cells interacts with peptide-MHC class II, which induces CD4 T cell activation leading to the coordination and regulation of other effector cells. CD4 molecules also bind to MHC class II, which helps augment TCR signaling4. Additionally, MHC class II expressed on activated T cells are capable of antigen presentation5 and can transduce signals into T cells, enhancing T cell proliferation and activity6. Y-3P was generated by repeatedly immunizing primed mice with activated T cells over the course of a year7. Y-3P reacts with I-A subregion-controlled A ⍺: A β complexes of all mouse strains except the responder strain H-2d. Y-3P is commonly used for in vivo blockade of TCR stimulation8,9 and MHC class II blocking10,11,12,13,14,15. Antigen Distribution MHC class II molecules are constitutively expressed on professional
antigen-presenting cells (APCs), including macrophages, monocytes, dendritic cells (DCs), and
B cells, and are induced on T cells upon activation. Ligand/Receptor CD3/TCR, CD4 NCBI Gene Bank ID UniProt.org Research Area Immunology . Innate Immunity Leinco Antibody AdvisorPowered by AI: AI is experimental and still learning how to provide the best assistance. It may occasionally generate incorrect or incomplete responses. Please do not rely solely on its recommendations when making purchasing decisions or designing experiments. The Y-3P clone is extensively used in in vivo mouse studies for MHC class II blocking and TCR stimulation blockade, making it a valuable tool for immunological research. Primary Applications in In Vivo StudiesMHC Class II Blocking: Y-3P is commonly employed to block MHC class II molecules in living mice, which prevents antigen presentation to CD4+ T cells. This application is particularly useful for studying immune responses and understanding the role of antigen presentation in various disease models. TCR Stimulation Blockade: The antibody is used to inhibit T cell receptor (TCR) stimulation by blocking the interaction between MHC class II molecules and CD4+ T cells. This mechanism allows researchers to examine T cell-dependent immune responses and their role in experimental conditions. Mechanism of ActionY-3P targets the I-A subregion-controlled A?:A? complexes found on professional antigen-presenting cells (APCs), including macrophages, monocytes, dendritic cells, and B cells. The antibody reacts with multiple mouse MHC class II haplotypes including I-Ab, I-Af, I-Ap, I-Aq, I-Ar, I-As, I-Au, I-Av, and weakly with I-Ak, but notably does not react with the H-2d haplotype. Practical ConsiderationsThe Y-3P antibody is formulated specifically for in vivo use as an InVivoMAb product, ensuring high purity (>95%), low endotoxin levels (<2EU/mg), and sterility through 0.2 µm filtration. It's produced in animal-free facilities and purified using Protein G to meet the stringent requirements for in vivo applications. The antibody is reported to inhibit I-A-restricted T cell responses, making it an effective tool for functional studies examining the role of MHC class II-mediated immune activation in mouse models. Researchers typically use this antibody to create controlled experimental conditions where MHC class II-dependent immune responses can be selectively blocked or modulated. The correct storage temperature for sterile packaged clone Y-3P (anti-mouse MHC Class II, Clone Y-3P) depends on the intended duration of storage:
Avoid repeated freeze-thaw cycles to maintain antibody integrity, and reference lot-specific datasheets for any manufacturer updates or particular formulations. These guidelines conform generally to practices for monoclonal antibody storage. Commonly Used Antibodies and Proteins with Y-3P in the LiteratureY-3P is a monoclonal antibody specific for mouse MHC class II (I-A), frequently used in immunology research to block T cell receptor (TCR) stimulation and MHC class II-mediated antigen presentation. Its primary function is to interfere with the interaction between MHC class II molecules and CD4+ T cells. In the literature, Y-3P is often used in conjunction with other antibodies and proteins that target key components of the immune response, especially in studies involving T cell activation, antigen presentation, and immune regulation. Associated Antibodies
Associated Proteins
Experimental Contexts
Summary Table
Key TakeawaysY-3P is predominantly used with antibodies and proteins that target T cell activation (anti-CD3, anti-CD28), co-receptors (anti-CD4), and markers of antigen-presenting cells. These combinations allow researchers to dissect the mechanisms of MHC class II-mediated immune responses, compare class I and class II functions, and validate the specificity of Y-3Ps effects using appropriate controls. Clone Y-3P is a monoclonal antibody used in immunology research, particularly for targeting Mouse MHC Class II (I-A) molecules. Key findings and applications from scientific literature involving clone Y-3P include:
These findings illustrate the significance of clone Y-3P in studying antigen presentation, immune cell maturation, and the role of MHC class II molecules in various immune contexts. References & Citations1. Yoshida R. Adv Immunol. 124:207-247. 2014. 2. Spencer JS, Kubo RT. J Exp Med. 169(3):625-640. 1989. 3. Wieczorek M, Abualrous ET, Sticht J, et al. Front Immunol. 8:292. 2017. 4. Artyomov MN, Lis M, Devadas S, et al. Proc Natl Acad Sci USA. 107(39):16916-16921. 2010. 5. Barnaba V, Watts C, de Boer M, et al. Eur J Immunol. 24(1):71-75. 1994. 6. Di Rosa F, D'Oro U, Ruggiero G, et al. Hum Immunol. 38(4):251-260. 1993. 7. Janeway CA Jr, Conrad PJ, Lerner EA, et al. J Immunol. 132(2):662-667. 1984. 8. Feng Y, van der Veeken J, Shugay M, et al. Nature. 528(7580):132-136. 2015. 9. Campisi L, Barbet G, Ding Y, et al. Nat Immunol. 17(9):1084-1092. 2016. 10. Stefanová I, Dorfman JR, Germain RN. Nature. 420(6914):429-434. 2002. 11. Andersson J, Stefanova I, Stephens GL, et al. Int Immunol. 19(4):557-566. 2007. 12. Younes SA, Punkosdy G, Caucheteux S, et al. PLoS Biol. 9(10):e1001171. 2011. 13. Guo L, Huang Y, Chen X, et al. Nat Immunol. 16(10):1051-1059. 2015. 14. Kawabe T, Yi J, Kawajiri A, et al. Nat Commun. 11(1):3366. 2020. 15. Kruse B, Buzzai AC, Shridhar N, et al. Nature. 618(7967):1033-1040. 2023. 16. Wei J, Loke P, Zang X, et al. J Exp Med. 208(8):1683-1694. 2011. 17. Alspach E, Lussier DM, Miceli AP, et al. Nature. 574(7780):696-701. 2019. 18. Hos BJ, Tondini E, Camps MGM, et al. Cell Rep. 41(2):111485. 2022. Technical ProtocolsCertificate of Analysis |
Formats Available
